Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases
Copyright © 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved..
BACKGROUND: Although nontuberculous mycobacteria (NTM) lung diseases can occur in association with lung cancer, no study has evaluated the effect of lung cancer treatment on NTM lung diseases. Therefore, the present study aimed to retrospectively examine the effect of lung cancer treatment on NTM lung diseases.
METHODS: Patients diagnosed with NTM lung diseases in combination with cytologically or histologically proven lung cancer between January 1, 2010 and October 31, 2014 were enroled. The clinical history of eligible patients was retrospectively reviewed.
RESULTS: Seven hundred twenty-eight patients were diagnosed with NTM lung diseases. Among these patients, 29 (3.9%) also had lung cancer. Of the 29 patients with NTM and lung cancer, 62% had Mycobacterium avium complex as the pathogenic organism. The most common lung cancer histology was adenocarcinoma (62.1%). Anti-cancer cytotoxic chemotherapy was administered to seven patients, and the two patients who did not receive NTM treatment showed worsening of their NTM lung disease.
CONCLUSION: Whether NTM lung disease should be treated during anti-cancer chemotherapy has not been not clarified by this study. Induction of anti-NTM therapy should be made after careful consideration, because the duration of anti-NTM treatment is long and anti-mycobacterial drugs have extensive effects on anti-cancer drugs. However, we think that anti-NTM therapy should be introduced after consideration of the worsening of symptoms and radiological findings associated with NTM lung disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Respiratory investigation - 55(2017), 1 vom: 01. Jan., Seite 45-50 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tsuji, Taisuke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 10.08.2017 Date Revised 10.08.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.resinv.2016.08.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM267443986 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM267443986 | ||
| 003 | DE-627 | ||
| 005 | 20231224220708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.resinv.2016.08.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0891.xml |
| 035 | |a (DE-627)NLM267443986 | ||
| 035 | |a (NLM)28012493 | ||
| 035 | |a (PII)S2212-5345(16)30101-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tsuji, Taisuke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.08.2017 | ||
| 500 | |a Date Revised 10.08.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: Although nontuberculous mycobacteria (NTM) lung diseases can occur in association with lung cancer, no study has evaluated the effect of lung cancer treatment on NTM lung diseases. Therefore, the present study aimed to retrospectively examine the effect of lung cancer treatment on NTM lung diseases | ||
| 520 | |a METHODS: Patients diagnosed with NTM lung diseases in combination with cytologically or histologically proven lung cancer between January 1, 2010 and October 31, 2014 were enroled. The clinical history of eligible patients was retrospectively reviewed | ||
| 520 | |a RESULTS: Seven hundred twenty-eight patients were diagnosed with NTM lung diseases. Among these patients, 29 (3.9%) also had lung cancer. Of the 29 patients with NTM and lung cancer, 62% had Mycobacterium avium complex as the pathogenic organism. The most common lung cancer histology was adenocarcinoma (62.1%). Anti-cancer cytotoxic chemotherapy was administered to seven patients, and the two patients who did not receive NTM treatment showed worsening of their NTM lung disease | ||
| 520 | |a CONCLUSION: Whether NTM lung disease should be treated during anti-cancer chemotherapy has not been not clarified by this study. Induction of anti-NTM therapy should be made after careful consideration, because the duration of anti-NTM treatment is long and anti-mycobacterial drugs have extensive effects on anti-cancer drugs. However, we think that anti-NTM therapy should be introduced after consideration of the worsening of symptoms and radiological findings associated with NTM lung disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cytotoxic chemotherapy | |
| 650 | 4 | |a Lung cancer | |
| 650 | 4 | |a Nontuberculous mycobacteria | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Tsuyuguchi, Kazunari |e verfasserin |4 aut | |
| 700 | 1 | |a Tachibana, Kazunobu |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Yohei |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Takehiko |e verfasserin |4 aut | |
| 700 | 1 | |a Minomo, Shojiro |e verfasserin |4 aut | |
| 700 | 1 | |a Atagi, Shinji |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumura, Akihide |e verfasserin |4 aut | |
| 700 | 1 | |a Hayashi, Seiji |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Katsuhiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiratory investigation |d 2012 |g 55(2017), 1 vom: 01. Jan., Seite 45-50 |w (DE-627)NLM217493343 |x 2212-5353 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2017 |g number:1 |g day:01 |g month:01 |g pages:45-50 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.resinv.2016.08.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2017 |e 1 |b 01 |c 01 |h 45-50 | ||